Medicine
Rezenopy 10 mg/0.11 mL nasal spray
Rezenopy 10 mg/0.11 mL nasal spray is a prescription medicine containing Naloxone for nasal use, marketed by Scienture, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze or expose to excessive heat above 40°C (104°F). REZENOPY nasal…
Key facts
- Active ingredient (INN)
- Naloxone
- Brand
- Rezenopy
- Strength
- 10 mg/0.11 mL
- Dosage form
- Nasal spray
- Route
- Nasal
- Packs
- 2 blister pack
- Marketing authorisation holder
- Scienture
- Manufacturer
- Scienture
- Origin register
- US FDA, United States
- Storage
- Do not freeze or expose to excessive heat above 40°C (104°F). REZENOPY nasal spray may freeze at cold temperatures. Store between 2°C to 25°C (36°F to 77°F). Excursions permitted up to 40°C (104°F). Store REZENOPY nasal spray in the blister and cartons provided. Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A06AH04 Naloxone
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 29 January 2026
- Identifiers
- RxCUI 2704891, 2704898DailyMed set ID 5bb502aa-014f-4a36-8972-42a9439168feNDC 83245-003Application NDA215487
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 2 blister pack in 1 carton / 1 vial, single-dose in 1 blister pack / .11 mL in 1 vial, single-dose | 83245-003-01 | Scienture | 29 January 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Naloxone
Clinical summary
Naloxone is an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression. MedsAcross supplies Naloxone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about NaloxoneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Narcan prescribing information (Emergent Devices) · U.S. National Library of Medicine, DailyMed
- Nyxoid: European public assessment report (EPAR) · European Medicines Agency
Need Rezenopy 10 mg/0.11 mL nasal spray for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.